GB8322199D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB8322199D0
GB8322199D0 GB838322199A GB8322199A GB8322199D0 GB 8322199 D0 GB8322199 D0 GB 8322199D0 GB 838322199 A GB838322199 A GB 838322199A GB 8322199 A GB8322199 A GB 8322199A GB 8322199 D0 GB8322199 D0 GB 8322199D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB838322199A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB838322199A priority Critical patent/GB8322199D0/en
Publication of GB8322199D0 publication Critical patent/GB8322199D0/en
Priority to DE8484109539T priority patent/DE3485225D1/en
Priority to EP84109539A priority patent/EP0141927B1/en
Priority to MX6893A priority patent/MX160431A/en
Priority to NZ209248A priority patent/NZ209248A/en
Priority to ZA846374A priority patent/ZA846374B/en
Priority to CA000461212A priority patent/CA1339818C/en
Priority to AU31973/84A priority patent/AU577303B2/en
Priority to IE212384A priority patent/IE58334B1/en
Priority to GR80121A priority patent/GR80121B/en
Priority to JP59171381A priority patent/JP2519882B2/en
Priority to ES535283A priority patent/ES8602791A1/en
Priority to ES543214A priority patent/ES8603888A1/en
Priority to ES543213A priority patent/ES8603887A1/en
Priority to US07/085,216 priority patent/US5075445A/en
Priority to MYPI87001753A priority patent/MY102896A/en
Priority to CS913914A priority patent/CZ283182B6/en
Priority to JP5246065A priority patent/JP2543822B2/en
Priority to SG114493A priority patent/SG114493G/en
Priority to BG98210A priority patent/BG61325B2/en
Priority to HK1260/93A priority patent/HK126093A/en
Priority to CY174694A priority patent/CY1746A/en
Priority to US08/311,291 priority patent/US6579981B1/en
Priority to US08/357,363 priority patent/US6573378B1/en
Priority to US08/884,731 priority patent/US5886215A/en
Priority to US09/238,777 priority patent/US6187922B1/en
Priority to US09/734,051 priority patent/US6388074B2/en
Pending legal-status Critical Current

Links

GB838322199A 1908-09-21 1983-08-18 Pharmaceutical composition Pending GB8322199D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GB838322199A GB8322199D0 (en) 1983-08-18 1983-08-18 Pharmaceutical composition
DE8484109539T DE3485225D1 (en) 1983-08-18 1984-08-10 ANTIVIRAL GUANINE DERIVATIVES.
EP84109539A EP0141927B1 (en) 1983-08-18 1984-08-10 Antiviral guanine derivatives
GR80121A GR80121B (en) 1983-08-18 1984-08-16 Compounds
NZ209248A NZ209248A (en) 1983-08-18 1984-08-16 Purine derivatives, pharmaceutical compositions and intermediates
MX6893A MX160431A (en) 1983-08-18 1984-08-16 A PROCEDURE TO PREPARE GUANINE DERIVATIVES
ZA846374A ZA846374B (en) 1983-08-18 1984-08-16 Pharmaceutical composition
CA000461212A CA1339818C (en) 1983-08-18 1984-08-16 Antiviral purine derivatives
AU31973/84A AU577303B2 (en) 1983-08-18 1984-08-16 9-substituted-2-amino purines
IE212384A IE58334B1 (en) 1983-08-18 1984-08-16 Antiviral guanine derivatives
JP59171381A JP2519882B2 (en) 1983-08-18 1984-08-17 Pharmaceutical composition for treating herpesvirus infection
ES535283A ES8602791A1 (en) 1983-08-18 1984-08-17 Antiviral guanine derivatives.
ES543213A ES8603887A1 (en) 1983-08-18 1985-05-16 Antiviral guanine derivatives.
ES543214A ES8603888A1 (en) 1983-08-18 1985-05-16 Antiviral guanine derivatives.
US07/085,216 US5075445A (en) 1983-08-18 1987-08-12 Guanine derivatives
MYPI87001753A MY102896A (en) 1983-08-18 1987-09-18 "9-4(hydroxy-3-hydroxymethybut-lyl) guanine and its derivatives
CS913914A CZ283182B6 (en) 1983-08-18 1991-12-19 Guanine derivatives and pharmaceutical compositions in which said derivatives are comprised
JP5246065A JP2543822B2 (en) 1983-08-18 1993-09-08 Guanine derivative
SG114493A SG114493G (en) 1983-08-18 1993-10-18 Antiviral guanine derivatives
BG98210A BG61325B2 (en) 1983-08-18 1993-11-10 Antiviral guanine derivatives
HK1260/93A HK126093A (en) 1983-08-18 1993-11-11 Antiviral guanine derivatives
CY174694A CY1746A (en) 1983-08-18 1994-06-03 Antiviral guanine derivatives
US08/311,291 US6579981B1 (en) 1908-09-21 1994-09-23 Antiviral guanine derivatives
US08/357,363 US6573378B1 (en) 1983-08-18 1994-12-15 Antiviral guanine derivatives
US08/884,731 US5886215A (en) 1983-08-18 1997-06-30 2-acetoxymethyl-4-halo-butyl-1-yl acetates
US09/238,777 US6187922B1 (en) 1983-08-18 1999-01-27 Process for the preparation of purine derivatives
US09/734,051 US6388074B2 (en) 1983-08-18 2000-12-11 Process for the preparation of purine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838322199A GB8322199D0 (en) 1983-08-18 1983-08-18 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB8322199D0 true GB8322199D0 (en) 1983-09-21

Family

ID=10547473

Family Applications (1)

Application Number Title Priority Date Filing Date
GB838322199A Pending GB8322199D0 (en) 1908-09-21 1983-08-18 Pharmaceutical composition

Country Status (3)

Country Link
GB (1) GB8322199D0 (en)
MY (1) MY102896A (en)
ZA (1) ZA846374B (en)

Also Published As

Publication number Publication date
ZA846374B (en) 1985-08-28
MY102896A (en) 1993-03-31

Similar Documents

Publication Publication Date Title
GB2136807B (en) Pharmaceutical compositions
DE3466476D1 (en) External pharmaceutical composition
GB8403668D0 (en) Pharmaceutical compositions
DE3467703D1 (en) Pharmaceutical compositions
GB8313217D0 (en) Pharmaceutical compositions
GB8325494D0 (en) Pharmaceutical compositions
GB8308126D0 (en) Pharmaceutical compositions
GB8325496D0 (en) Pharmaceutical compositions
GR80293B (en) Pharmaceutical composition
GB8329043D0 (en) Pharmaceutical compositions
GB2136806B (en) Pharmaceutical compositions
GB8317595D0 (en) Pharmaceutical compositions
CY1503A (en) Pharmaceutical compositions
GB8412569D0 (en) Pharmaceutical compositions
GB8323553D0 (en) Pharmaceutical compositions
GB8417154D0 (en) Pharmaceutical composition
GB8406132D0 (en) Pharmaceutical compositions
EP0136006A3 (en) Pharmaceutical compositions
GB8407735D0 (en) Pharmaceutical composition
GB8300767D0 (en) Pharmaceutical compositions
GB8305697D0 (en) Pharmaceutical compositions
GB8308414D0 (en) Pharmaceutical composition
GB2150435B (en) Pharmaceutical compositions
GB8423725D0 (en) Pharmaceutical composition
ZA846374B (en) Pharmaceutical composition